Abstract Body

Background: Despite ample evidence of the effectiveness of several interventions to prevent HIV among people who use drugs, the global goal of reducing transmission by 50% by 2015 is not likely going to be achieved. Coverage of these key interventions such as needle and syringe programs and medically assisted therapy remain low particularly in low and middle income countries. In addition to HIV, people who use drugs are also at higher risk for a number of other medical complications including tuberculosis and viral hepatitis. In most countries however, access to treatment for these infections remains poor and treatment services are often segregated. Implementing treatment as prevention for people who use drugs poses many challenges including delays in entering into care, provider reluctance to commence antiretroviral therapy and issues with adherence in those who are actively using drugs. Additionally, incarceration of people who use drugs further reduces access to HIV and other treatment as well as fuel the twin epidemic of HIV and tuberculosis in this population. Conclusions: Despite evidence of effectiveness and cost-effectiveness of key interventions to prevent and treat HIV infection in people who use drugs, the current global response to the HIV epidemic in this population remains poor. Although policy shifts with increasing coverage of key interventions are beginning to take place in several countries with high disease burden, criminalisation of drug use, incarceration and stigma and discrimination continue to present as main barriers to an effective combination prevention and treatment response. A concerted global effort that addresses individual as well as structural and systematic barriers is needed if we are to expect a decline in HIV transmission among people who use drugs and improve the health and well-being of these individuals.